About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Criminal Charges may Be Brought Against Austrian Health Researcher

by Rajashri on August 19, 2008 at 2:49 PM
Font : A-A+

 Criminal Charges may Be Brought Against Austrian Health Researcher

Clinical trials conducted by researchers at a major medical school in Austria were riddled with procedural and ethical problems, a new report by the Austrian government has charged, the Nature Publishing Group has revealed.

The Agency for Health and Food Safety report says University of Innsbruck Professor Hannes Strasser failed to get necessary approvals for the trials, and neglected to adequately inform patients about the nature of the procedure, according to Nature.

Advertisement

Strasser, who designed the study, is also charged with failing to insure the volunteers.

The trials tested a new treatment for urinary incontinence on hundreds of women and men. The therapy involved removing tissue from a patient's arm to create muscle stem cells, then injecting these cells into the same person's urinary sphincter muscle.
Advertisement

Findings were published last year in the British medical journal The Lancet.

A lawyer representing some of the patients said many had experienced serious side effects, such as the sealing of the urinary sphincter and bladder rupture, according to Nature, a leading scientific journal based in Britain.

"This is a very grave scandal for the university, and the pressure on the public prosecutor to bring criminal charges will be very high," the lawyer, Thomas Juen, is quoted as saying.

The health agency report also says that documents related to the clinical trials may have been forged, and that patients were not properly randomised in the study.

The university hospital has barred Strasser -- who has written an open letter to university authorities denying any wrongdoing -- from treating patients.

Strasser and colleagues reported that the new therapy cured urinary incontinence in more than 90 percent of women and 50 percent of men in the trial, compared to less than 10 percent of patients in a control group receiving a standard treatment of collagen injections.

Georg Bartsch, head of the university's urology department, was cleared of wrongdoing in the report even though he is listed in the study published in The Lancet as one of five co-authors who did "all investigations and treatments" related to the therapies, Nature said.

The Lancet said in a statement it was reviewing the government report, and was in touch with both Austrian authorities and the authors of the report.

Source: AFP
RAS/S
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Health Insurance - India 

Recommended Reading
Stem Cells - Fundamentals
Encyclopedia section of medindia gives general info about Stem Cells...
Bone Marrow Transplantation - Animation
Animation and slides providing graphic explanation of Bone Marrow Transplantation (BMT)/Stem Cell ....
Peripheral Vascular Disease Could Be Tackled With Stem Cells
Two separate studies show that multi-potent adult progenitor stem cells extracted from bone marrow ....
Health Insurance - India
Health insurance has emerged as one of the fastest growing segments in the non-life insurance indust...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use